Lioresal: Targeted Spasticity Relief for Improved Mobility
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.75 | $44.72 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $67.08 $61.92 (8%) | 🛒 Add to cart |
| 120 | $0.66 | $89.44 $79.12 (12%) | 🛒 Add to cart |
| 180 | $0.62 | $134.16 $111.80 (17%) | 🛒 Add to cart |
| 270 | $0.61 | $201.24 $163.40 (19%) | 🛒 Add to cart |
| 360 | $0.59
Best per pill | $268.32 $214.14 (20%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.18 | $65.36 (0%) | 🛒 Add to cart |
| 60 | $1.82 | $130.72 $109.22 (16%) | 🛒 Add to cart |
| 90 | $1.69 | $196.08 $152.22 (22%) | 🛒 Add to cart |
| 120 | $1.63 | $261.44 $195.22 (25%) | 🛒 Add to cart |
| 180 | $1.57 | $392.16 $282.08 (28%) | 🛒 Add to cart |
| 270 | $1.52
Best per pill | $588.24 $411.08 (30%) | 🛒 Add to cart |
Synonyms | |||
Lioresal (baclofen) is a centrally-acting skeletal muscle relaxant specifically designed for the management of severe spasticity resulting from conditions such as multiple sclerosis, spinal cord injuries, and other neurological disorders. It functions as a gamma-aminobutyric acid (GABA) agonist, primarily exerting its effects at the spinal cord level to inhibit monosynaptic and polysynaptic reflex transmission. This targeted mechanism of action reduces muscle hypertonia and painful spasms, facilitating enhanced physical function, ease of care, and an improved quality of life for patients. Proper administration under strict medical supervision is paramount to achieving optimal therapeutic outcomes while minimizing potential risks.
Features
- Active Pharmaceutical Ingredient: Baclofen
- Available in oral tablet formulations (10 mg and 20 mg strengths) and intrathecal solution for infusion via an implanted pump.
- Mechanism of Action: Agonist at GABA-B receptors.
- Primary Indication: Management of signs and symptoms of spasticity.
- Prescription-only medication, requiring careful titration.
Benefits
- Significant Reduction in Muscle Spasticity: Directly targets the neural pathways responsible for hypertonia, leading to a measurable decrease in muscle tone and resistance to passive movement.
- Alleviation of Painful Muscle Spasms: By dampening excessive reflex activity, it effectively reduces the frequency and intensity of painful clonus and spasms, providing considerable comfort.
- Enhanced Functional Capacity and Mobility: Patients often experience improved range of motion, which can facilitate participation in physical therapy, ambulation, and activities of daily living.
- Ease of Nursing and Physiotherapy Care: Reduced rigidity and spasms make positioning, hygiene, and therapeutic stretching maneuvers significantly easier for caregivers.
- Potential for Improved Sleep and Quality of Life: The relief from disruptive nocturnal spasms and pain can contribute to better sleep patterns and overall well-being.
Common use
Lioresal is primarily indicated for the management of spasticity associated with multiple sclerosis and spinal cord lesions (e.g., trauma, disease). It is also used off-label for the treatment of other conditions involving spasticity, such as cerebral palsy, stroke, and certain forms of dystonia. Its use is reserved for patients for whom spasticity causes significant interference with daily function, sleep, or hygiene. The intrathecal route is typically reserved for severe, intractable spasticity in patients who are unresponsive to oral therapy or who experience intolerable central nervous system side effects at effective oral doses.
Dosage and direction
Oral Administration: The dosage must be individualized for each patient. Therapy should be initiated at a low dose and gradually titrated upward to achieve an optimal effect.
- Initial Dose: 5 mg administered three times daily.
- Titration: The dose may be increased by 5 mg per dose every three days to a maximum of 80 mg daily (20 mg q.i.d.), based on patient response and tolerability.
- Maintenance Dose: The effective dose typically ranges from 40-80 mg daily, divided into three or four doses.
- Discontinuation: Abrupt withdrawal must be avoided. Dosage should be reduced gradually over a period of at least 1-2 weeks to prevent withdrawal syndrome (hallucinations, seizures, pruritus, etc.).
Intrathecal Administration:
- Reserved for severe cases and administered via a surgically implanted pump.
- Requires screening via a bolus injection to assess responsiveness before pump implantation.
- Dosage is highly individualized and programmed by a specialist. The maintenance infusion dose typically ranges from 12 mcg/day to 2000 mcg/day.
Direction: Tablets should be taken with food or milk to minimize gastrointestinal upset. Doses should be spaced evenly throughout the waking hours.
Precautions
- Renal Impairment: Baclofen is primarily excreted unchanged by the kidneys. Dosage reduction is necessary in patients with impaired renal function.
- Psychiatric and Neurological Conditions: Use with extreme caution in patients with psychiatric disorders, schizophrenia, or confusional states, as baclofen can exacerbate these conditions.
- Stroke Patients: Caution is advised in post-stroke patients, as efficacy has been less consistently demonstrated and there may be an increased risk of sedation.
- Autonomic Dysreflexia: Patients with spinal cord injury at T6 or above should be monitored for autonomic dysreflexia, which may be masked by baclofen.
- Pregnancy and Lactation: Use during pregnancy only if the potential benefit justifies the potential risk to the fetus (Category C). Baclofen is excreted in human milk; a decision should be made to discontinue nursing or discontinue the drug.
- Operative Warning: Patients should be cautioned about the potential for drowsiness and dizziness, which may impair their ability to operate machinery or drive.
Contraindications
- Hypersensitivity to baclofen or any component of the formulation.
- For intrathecal administration: Presence of infection, spinal canal obstruction, or individuals who are not appropriate surgical candidates for pump implantation.
Possible side effect
Common side effects are often dose-related and may diminish over time. They primarily involve the central nervous and gastrointestinal systems.
- Very Common (>10%): Drowsiness, sedation, dizziness, weakness, fatigue, nausea.
- Common (1-10%): Headache, insomnia, confusion, hypotension, constipation, urinary frequency.
- Uncommon (0.1-1%): Depression, hallucinations, paresthesia, blurred vision, dry mouth, diarrhea, erectile dysfunction, rash.
- Rare (<0.1%): Seizures (especially on withdrawal), respiratory depression, syncope, elevated liver enzymes.
Drug interaction
- CNS Depressants (Alcohol, Opioids, Benzodiazepines, Sedating Antihistamines): Concomitant use can lead to additive sedative effects, profound drowsiness, respiratory depression, and dizziness. Dose adjustments of one or both agents may be required.
- Antihypertensives: May potentiate the blood-pressure-lowering effects, leading to orthostatic hypotension.
- MAO Inhibitors and Tricyclic Antidepressants: May increase CNS depressive effects.
- Levodopa-Carbidopa: Reports of worsened mental confusion, hallucinations, and agitation.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the dose to make up for a missed one, as this increases the risk of adverse effects.
Overdose
Manifestations: Signs of overdose are primarily an exaggeration of known pharmacological effects. Key symptoms include profound drowsiness, lightheadedness, dizziness, vomiting, profound muscular weakness, hyporeflexia, respiratory depression, progression to coma, and seizures. Bradycardia, hypotension, and hypothermia may also occur. Management: There is no specific antidote for baclofen overdose. Management is supportive and symptomatic. This includes securing the airway, ensuring adequate ventilation, and maintaining cardiovascular function. Gastric lavage or activated charcoal may be considered if ingestion was recent. Hemodialysis may be beneficial in cases of significant overdose, particularly in patients with renal impairment. Seizures may be treated with benzodiazepines.
Storage
- Store at room temperature (20°C to 25°C or 68°F to 77°F), protected from light and moisture.
- Keep in the original container, tightly closed.
- Keep out of reach of children and pets.
- Do not flush unused medication down the toilet or pour it into a drain. Dispose of it through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- “As a neurologist treating MS patients for over 20 years, Lioresal remains a cornerstone of our spasticity management protocol. The titration process is key, but the functional improvements we see in compliant patients are often remarkable.” – Dr. E. Vance, MD
- “After my spinal cord injury, the constant spasms were debilitating. Starting on Lioresal was a turning point. The adjustment period had some drowsiness, but now my muscle tightness is manageable, and my physiotherapy sessions are far more productive.” – Mark T.
- “The efficacy is undeniable for severe spasticity, but the side effect profile, particularly sedation and weakness, requires very careful patient selection and dose management. It’s a powerful tool, but not one for casual use.” – Clinical Pharmacist Review
- “Managing my son’s cerebral palsy-related spasticity has been a long journey. Intrathecal Lioresal via the pump was a major decision, but it has given him a level of comfort and reduced tone that oral medications never could, with fewer systemic side effects.” – Parent Caregiver